Evan Yu, MD, Oncology, Seattle, WA, Seattle Cancer Care Alliance

EvanYa-WenYuMD

Oncology Seattle, WA

Hematologic Oncology

Associate Professor, Medicine, University of Washington School of Medicine

Overview of Dr. Yu

Dr. Evan Yu is an oncologist in Seattle, WA and is affiliated with multiple hospitals in the area, including Seattle Cancer Care Alliance, UW Medicine/Harborview Medical Center, and UW Medicine/University of Washington Medical Center. He received his medical degree from University of Washington School of Medicine and has been in practice 19 years. Dr. Yu accepts several types of health insurance, listed below. He is one of 32 doctors at UW Medicine/Harborview Medical Center and one of 136 doctors at UW Medicine/University of Washington Medical Center who specialize in Oncology.

Education & Training

  • Brigham and Women's HospitalFellowship, Hematology/Oncology, 2001 - 2004
  • Stanford UniversityResidency, Internal Medicine, 1998 - 2001
  • University of Washington School of MedicineClass of 1998

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 2004 - 2021
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Association of Clonal Hematopoiesis in DNA Repair Genes with Prostate Cancer Plasma Cell-Free DNA Testing Interference  
    Michael T Schweizer, Petros Grivas, Heather H Cheng, Evan Y Yu, JAMA Oncology

Lectures

  • Pembrolizumab (pembro) plus olaparib in docetaxel-pretreated patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC): Cohort A of the phase 1b/2 KEYN... 
    2019 ASCO Annual Meeting - 6/1/2019
  • A randomized phase II study of atezolizumab plus recombinant human IL-7 (CYT107) or atezolizumab alone in patients with locally advanced or metastatic urothelial carci... 
    2019 ASCO Annual Meeting - 6/1/2019
  • Targeted Therapies in Advanced Urothelial Cancer 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Press Mentions

  • Patient-Reported Outcomes from TITAN: Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer - Neeraj Agarwal
    Patient-Reported Outcomes from TITAN: Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer - Neeraj AgarwalJune 5th, 2020
  • Sequencing Treatments in Metastatic Prostate Cancer - Evan Yu
    Sequencing Treatments in Metastatic Prostate Cancer - Evan YuJune 5th, 2020
  • Neoadjuvant Systemic Therapy for Prostate Cancer: If a PUNCH Is Good, What Will It Take to Score a Knockout?
    Neoadjuvant Systemic Therapy for Prostate Cancer: If a PUNCH Is Good, What Will It Take to Score a Knockout?February 7th, 2020
  • Join now to see all

Professional Memberships

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
    BCBS Blue Card PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    First Choice
    Great West PPO
    Health Net Oregon PPO
    Multiplan PPO
    ODS Network
    Premera BCBS Heritage & Heritage Plus 1
    Providence Health System Personal Option
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment